Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Montelukast for prevention of bronchopulmonary dysplasia
IRCT20251213068304N1Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of montelukast in bronchopulmonary dysplasia (BPD), sponsored by Iran University of Medical Sciences. Started Apr 2025; status: completed.
02
Drugs
montelukast
03
Conditions
bronchopulmonary dysplasia (BPD)
Beyond the preview
Go deeper on IRCT20251213068304N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20251213068304N1.